ALPS Advisors’s Ascendis Pharma A/S ASND Stock Holding History

ALPS Advisors’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-30,416	Closed	-$3.14M	–	1028
2022 Q3	$3.14M	Sell	30,416 -214	-0.7%	-$20.3K	0.03%	216
2022 Q2	$2.85M	Buy	+30,630	New	+$2.89M	0.03%	245
2019 Q2	–	Sell	-70,468	Closed	-$8.29M	–	880
2019 Q1	$8.29M	Sell	70,468 -26,667	-27%	-$2.34M	0.06%	132
2018 Q4	$6.09M	Buy	97,135 +31,687	+48%	+$1.99M	0.05%	139
2018 Q3	$4.64M	Buy	65,448 +12,124	+23%	+$835K	0.03%	168
2018 Q2	$3.55M	Buy	53,324 +4,549	+9%	+$299K	0.02%	194
2018 Q1	$3.19M	Buy	48,775 +8,478	+21%	+$477K	0.03%	175
2017 Q4	$1.61M	Buy	40,297 +8,368	+26%	+$304K	0.01%	209
2017 Q3	$1.16M	Buy	31,929 +2,665	+9%	+$76.5K	0.01%	231
2017 Q2	$812K	Buy	29,264 +2,144	+8%	+$56.6K	0.01%	261
2017 Q1	$759K	Sell	27,120 -3,176	-10%	-$80.3K	0.01%	244
2016 Q4	$613K	Buy	+30,296	New	+$605K	﹤0.01%	267
2016 Q2	–	Sell	-28,259	Closed	-$524K	–	611
2016 Q1	$524K	Sell	28,259 -4,843	-15%	-$86K	0.01%	212
2015 Q4	$606K	Sell	33,102 -4,208	-11%	-$73.8K	0.01%	265
2015 Q3	$6.6K	Buy	37,310 +13,684	+58%	+$266K	0.01%	237
2015 Q2	$415K	Buy	+23,626	New	+$413K	﹤0.01%	623

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

ALPS Advisors's ASND Position: Q4 2022 in Review

ALPS Advisors sold out of Ascendis Pharma A/S (ASND) in Q4 2022, closing a stake of 30,416 shares — an estimated $3.14M sold.

ALPS Advisors first reported a position in ASND in Q2 2015 and held it in 16 quarters. The position peaked at $8.29M in Q1 2019. 187 funds tracked by Wall St. Rank hold ASND as of Q4 2022.

ALPS Advisors reported no remaining Ascendis Pharma A/S position as of Q4 2022 after selling out during the quarter.
ALPS Advisors sold 30,416 Ascendis Pharma A/S shares in Q4 2022, an estimated $3.14M.
ALPS Advisors first reported a position in Ascendis Pharma A/S in Q2 2015 and held it in 16 quarters.
ALPS Advisors's Ascendis Pharma A/S position peaked at $8.29M in Q1 2019.
187 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2022.

Based on ALPS Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.